MDxHealth Raises $20M in Registered Direct Offering at $0.454/Share
MDXH sits 60% above its 52-week low of $0.4 on elevated volume (6.4× avg).
Summary
MDxHealth raised $20 million in a registered direct offering at $0.454 per share, a 29% discount to market, nearly doubling its outstanding shares.
Key Events · Financing and Capital Events · MDXH
-
Registered Direct Offering
Issued 44,052,862 ordinary shares at $0.454 per share, raising approximately $20.0 million in net proceeds.
-
Massive Dilution
Post-offering outstanding shares total 95,417,382, up from 51,364,520 pre-offering — an 85.8% increase in share count.
-
Deep Discount Pricing
Offering price of $0.454 represents a 29% discount to the current market price of $0.6397, signaling distress.
-
Nasdaq Compliance Pressure
Follows Nasdaq notices for failing the $1.00 minimum bid price and $35 million minimum market value requirements.
Analysis · MDXH · Industrial Applications And Services
MDxHealth sold 44.05 million shares at $0.454 each, raising about $20 million. The price is a 29% discount to the current market price of $0.6397, reflecting the company's distressed position after Nasdaq delisting notices for both bid price and market value. The offering nearly doubles the share count from 51.36 million to 95.42 million, causing significant dilution to existing shareholders. Proceeds will fund working capital and product development, extending the company's runway but at a steep cost to current holders.
How filings like this one have moved
In the 30 days to Oct 31, 2026, 40% of the 987 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDXH was trading at $0.64 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $23.7M. The 52-week trading range was $0.40 to $5.33. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.